Avatrombopag tablets per dose
Avatrombopag is an oral medication commonly used to treat adults with chronic immune thrombocytopenia (ITP). Its dosage is usually adjusted according to the patient's specific condition and the doctor's recommendations to ensure optimal therapeutic effects and minimal side effects.
Generally speaking, the standard dose of avatrombopag tablets is20 milligrams (mg), and the specific dosage and usage are as follows:
1.Starting dose: Based on the patient's platelet count and individual condition, the starting dose of avatrombopag tablets is usually 20 milligrams (mg), usually taken orally once daily. The maximum dose in the later period shall not exceed 40mg.
2.Adjust dosage: During the treatment process, based on the patient's platelet count and treatment response, the doctor may gradually adjust the dosage of avatrombopag tablets to achieve the best therapeutic effect. Dosage adjustments may be made based on the patient's platelet count and clinical symptoms, so patients should receive regular medical examination and follow-up.

3.Maintenance dose: Once satisfactory platelet count and symptom control are achieved, the doctor may maintain the dose of avatrombopag at a stable level.
4.Taking time: Avatrombopag tablets are usually taken on an empty stomach. Avoid taking them with food or other drugs at the same time to ensure the absorption and effect of the drug.
5.Dose adjustment and discontinuation: During the treatment process, the doctor may make dosage adjustments based on the patient's treatment response and clinical status, or temporarily discontinue the drug as needed. Any dosage adjustment or discontinuation should be made under the guidance of a physician.
In general, the dosage and usage of avatrombopag tablets should be based on the patient's specific condition and the recommendations of the doctor. Patients should follow the doctor's instructions and take the correct dosage and usage to ensure the best therapeutic effect, and promptly report any discomfort or adverse reactions to the doctor.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)